When comparing PI3K/Akt pathway activity among individual BC-PDM models, samples were divided into two groups, too, with one group again consisting of HR + samples and the other containing all TNBC and HER2+ samples (Fig. 5C). This evidence concerns the gene AKT1 and breast cancer.